Your browser doesn't support javascript.
loading
A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons.
Oliva, Gaetano; Nieto, Javier; Foglia Manzillo, Valentina; Cappiello, Silvia; Fiorentino, Eleonora; Di Muccio, Trentina; Scalone, Aldo; Moreno, Javier; Chicharro, Carmen; Carrillo, Eugenia; Butaud, Therese; Guegand, Laurie; Martin, Virginie; Cuisinier, Anne-Marie; McGahie, David; Gueguen, Sylvie; Cañavate, Carmen; Gradoni, Luigi.
Afiliação
  • Oliva G; Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy.
  • Nieto J; Leishmaniasis and Chagas Disease Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Foglia Manzillo V; Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy.
  • Cappiello S; Department of Veterinary Clinical Sciences, University Federico II, Naples, Italy.
  • Fiorentino E; Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy.
  • Di Muccio T; Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy.
  • Scalone A; Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy.
  • Moreno J; Leishmaniasis and Chagas Disease Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Chicharro C; Leishmaniasis and Chagas Disease Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Carrillo E; Leishmaniasis and Chagas Disease Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Butaud T; Safety and Efficacy Unit, Biological R&D, VIRBAC BIO3, Carros, France.
  • Guegand L; Safety and Efficacy Unit, Biological R&D, VIRBAC BIO3, Carros, France.
  • Martin V; Safety and Efficacy Unit, Biological R&D, VIRBAC BIO3, Carros, France.
  • Cuisinier AM; Safety and Efficacy Unit, Biological R&D, VIRBAC BIO3, Carros, France.
  • McGahie D; Medical Department, VIRBAC, Carros, France.
  • Gueguen S; Safety and Efficacy Unit, Biological R&D, VIRBAC BIO3, Carros, France.
  • Cañavate C; Leishmaniasis and Chagas Disease Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
  • Gradoni L; Unit of Vector-borne Diseases and International Health, MIPI Department, Istituto Superiore di Sanità, Rome, Italy.
PLoS Negl Trop Dis ; 8(10): e3213, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25299614
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmania infantum / Doenças Endêmicas / Doenças do Cão / Vacinas contra Leishmaniose / Leishmaniose Visceral Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmania infantum / Doenças Endêmicas / Doenças do Cão / Vacinas contra Leishmaniose / Leishmaniose Visceral Idioma: En Ano de publicação: 2014 Tipo de documento: Article